Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 14/20 | 1.00 |
| ▸ | TTR | P02766 | 4/20 | 0.70 |
| ▸ | DPP4 | P27487 | 1/20 | 0.70 |
| ▸ | IAPP | P10997 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.61 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.61 |
| ▸ | GMNN | O75496 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | EGFR | P00533 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | ESR1 | P03372 | 1/20 | 0.61 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.61 |
| ▸ | LCK | P06239 | 1/20 | 0.61 |
| ▸ | FYN | P06241 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19359050 | 1.00 | APP (1.00) | APPTTRDPP4IAPPCYP3A4 | |
| SCHEMBL19358970 | 1.00 | APP (1.00) | APPTTRDPP4IAPPCYP3A4 | |
| SCHEMBL883450 | 1.00 | APP (1.00) | APPTTRDPP4IAPPCYP3A4 | |
| SCHEMBL19358968 | 1.00 | APP (1.00) | APPTTRDPP4IAPPCYP3A4 | |
| SCHEMBL19358979 | 1.00 | APP (1.00) | APPTTRDPP4IAPPCYP3A4 | |
| SCHEMBL16428904 | 1.00 | APP (1.00) | APPTTRDPP4IAPPCYP3A4 | |
| SCHEMBL19358995 | 1.00 | APP (1.00) | APPTTRDPP4IAPPCYP3A4 | |
| SCHEMBL1427296 | 1.00 | APP (1.00) | APPTTRDPP4IAPPCYP3A4 | |
| SCHEMBL1427294 | 1.00 | APP (1.00) | APPTTRDPP4IAPPCYP3A4 | |
| SCHEMBL16428905 | 1.00 | APP (1.00) | APPTTRDPP4IAPPCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119523819-A | Light-responsive antioxidant preparation, and preparation method and application thereof | 上海百雀羚生物科技有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-111296445-A | Laurella solanacearum targeted nano medicament and preparation method and application thereof | 江苏科技大学 | 2020-06-19 | — | — | CN | claimed |
| WO-2017161093-A1 | CAFFEIC ACID DERIVATIVES AND USES THEREOF | MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (US) | 2017-09-21 | — | — | WO | claimed |
| CN-104365598-B | Caffeic acid and the application of Arrcostab in bacterial wilt control thereof | JIANGSU UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2016-03-30 | — | — | CN | claimed |
| US-20160022605-A1 | METHODS FOR REDUCING MICROSATELLITE INSTABILITY INDUCED BY CHEMOTHERAPY AND METHODS FOR SCREENING ANTIOXIDANTS THAT SUPPRESS DRUG-INDUCED MICROSATELLITE INSTABILITY WHILE ENHANCING THE CYTOTOXICITY OF CHEMOTHERAPEUTIC AGENTS | CHANG CHRISTINA LING (TW) | 2016-01-28 | — | — | US | claimed |
| US-20150274633-A2 | PAIN RELIEF COMPOUNDS | UNIVERSITÉ CLERMONT AUVERGNE (FR) | 2015-10-01 | — | — | US | claimed |
| CN-120004738-A | Octyl vanillate and preparation method and application thereof | 广东电网有限责任公司电力科学研究院 | 2025-05-16 | — | — | CN | disclosed |
| CN-119523819-A | Light-responsive antioxidant preparation, and preparation method and application thereof | 上海百雀羚生物科技有限公司 | 2025-02-28 | — | — | CN | disclosed |
| US-11744820-B2 | Inhibitors of microbially induced amyloid | AXIAL THERAPEUTICS, INC. (US) | 2023-09-05 | — | — | US | disclosed |
| CN-111296445-B | Laurella solanacearum targeted nano medicament and preparation method and application thereof | 江苏科技大学 | 2022-03-11 | — | — | CN | disclosed |
| US-20220040145-A1 | INHIBITORS OF MICROBIALLY INDUCED AMYLOID | AXIAL THERAPEUTICS, INC. | 2022-02-10 | — | — | US | disclosed |
| US-11147792-B2 | Inhibitors of microbially induced amyloid | AXIAL THERAPEUTICS, INC. (US) | 2021-10-19 | — | — | US | disclosed |
| CN-111296445-A | Laurella solanacearum targeted nano medicament and preparation method and application thereof | 江苏科技大学 | 2020-06-19 | — | — | CN | disclosed |
| US-20080008734-A1 | Reduction of skin irritation caused by biomedical electrodes | AXELGAARD MANUFACTURING COMPANY, LTD. | 2008-01-10 | — | — | US | disclosed |
| WO-2008005672-A2 | REDUCTION OF SKIN IRRITATION CAUSED BY BIOMEDICAL ELECTRODES | AXELGAARD MANUFACTURING COMPANY, LTD. (US) | 2008-01-10 | — | — | WO | disclosed |
| US-6265344-B1 | WHICH IS SUITABLE FOR A FILM FOR A VIDEO PRINTER. | RICOH COMPANY, LTD. (JP) | 2001-07-24 | — | — | US | disclosed |
| US-5952263-A | PROTECTIVE LAYER FORMED OF A RESIN WITH MICROSCOPICALLY ROUGH SURFACE HORIZONTALLY CUT AT EQUALLY SPACED INTERVALS; HIGH TRANSPARENCY, IMAGE QUALITY WITHOUT WHITE STREAKS AND NONSTICKING TO THERMAL PRINTHEADS | RICOH COMPANY, LTD. (JP) | 1999-09-14 | — | — | US | disclosed |
| US-5935899-A | PROTECTIVE LAYER COMPRISING SPHERICAL FILLER AND AN IRREGULAR SHAPED FILLER; NON-STICKING TO THERMAL HEAD, NO WHITE STRIPE, DECREASED HEAD DEFACEMENT; COMPUTERS, FACSIMILE MACHINES; LABEL PRINTERS | RICOH COMPANY, LTD. (JP) | 1999-08-10 | — | — | US | disclosed |
| US-5866507-A | BLEND OF BINDER AND COLORING AGENT | RICOH COMPANY, LTD. (JP) | 1999-02-02 | — | — | US | disclosed |
| US-5792724-A | HIGH TRANSMITTANCE DENSITY, EXCELLENT REPRODUCIBILITY OF FINE DOT AND HALF TONE IMAGES; MIXTURE OF BINDER RESINS WITH DIFFERENT GLASS TRANSIFION TEMPERATURES | RICOH CO., LTD. (JP) | 1998-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11744820-B2 | Inhibitors of microbially induced amyloid | APP, PSEN1, BACE1 | APP 1/4885TTR 12/4885DPP4 1362/4885 |
| US-20220040145-A1 | INHIBITORS OF MICROBIALLY INDUCED AMYLOID | APP, PSEN1, BACE1 | APP 1/4885TTR 12/4885DPP4 1362/4885 |
| US-20150274633-A2 | PAIN RELIEF COMPOUNDS | OPRL1, OPRK1, TRPV1 | APP 3114/4885TTR 1663/4885DPP4 969/4885 |
| US-20160022605-A1 | METHODS FOR REDUCING MICROSATELLITE INSTABILITY INDUCED BY CHEMOTHERAPY AND METHODS FOR SCREENING ANTIOXIDANTS THAT SUPPRESS DRUG-INDUCED MICROSATELLITE INSTABILITY WHILE ENHANCING THE CYTOTOXICITY OF CHEMOTHERAPEUTIC AGENTS | MSH2, PCNA, PMS2 | APP 4384/4885TTR 1717/4885DPP4 4601/4885 |
| US-11147792-B2 | Inhibitors of microbially induced amyloid | APP, PSEN1, BACE1 | APP 1/4885TTR 12/4885DPP4 1362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.